Validation of novel fluorescence assays for the routine screening of drug susceptibilities of Trichomonas vaginalis | Zendy

Manal J. Natto | Zendy; Francesca Savioli | Zendy; Neils B. Quashie | Zendy; Christophe Dardonville | Zendy; Boris Rodenko | Zendy; Harry P. de Koning | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Validation of novel fluorescence assays for the routine screening of drug susceptibilities of Trichomonas vaginalis

Author(s) -

Manal J. Natto,

Francesca Savioli,

Neils B. Quashie,

Christophe Dardonville,

Boris Rodenko,

Harry P. de Koning

Publication year - 2012

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkr572

Subject(s) - resazurin , trichomonas vaginalis , plate reader , high throughput screening , chemistry , viability assay , propidium iodide , metabolite , trichomoniasis , biochemistry , biology , fluorescence , microbiology and biotechnology , in vitro , programmed cell death , physics , quantum mechanics , medicine , apoptosis , pathology

To evaluate existing protocols, based on Alamar blue (resazurin), for the routine determination of drug susceptibility in trichomonads, develop new ones and validate these by screening small antiprotozoal libraries.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research